These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11703174)

  • 1. Plasmin-independent gelatinase B (matrix metalloproteinase-9) release by monocytes under the influence of urokinase.
    Menshikov MY; Elizarova EP; Kudryashova E; Timofeyeva AV; Khaspekov Y; Beabealashvilly RS; Bobik A
    Biochemistry (Mosc); 2001 Sep; 66(9):954-9. PubMed ID: 11703174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fibrinolytic System in Health and Disease.
    Kwaan HC
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
    Zhang Y; Zhou ZH; Bugge TH; Wahl LM
    J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
    J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
    Wysocki AB; Kusakabe AO; Chang S; Tuan TL
    Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of serine proteinase inhibitors on bone resorption in vitro.
    Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA
    J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
    Chu EK; Cheng J; Foley JS; Mecham BH; Owen CA; Haley KJ; Mariani TJ; Kohane IS; Tschumperlin DJ; Drazen JM
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):628-38. PubMed ID: 16794260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
    Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
    Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
    Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.
    Davis GE; Pintar Allen KA; Salazar R; Maxwell SA
    J Cell Sci; 2001 Mar; 114(Pt 5):917-30. PubMed ID: 11181175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis.
    Menshikov M; Elizarova E; Plakida K; Timofeeva A; Khaspekov G; Beabealashvilli R; Bobik A; Tkachuk V
    Biochem J; 2002 Nov; 367(Pt 3):833-9. PubMed ID: 12117412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.
    Endo A; Nagai N; Urano T; Ihara H; Takada Y; Hashimoto K; Takada A
    Neurosci Lett; 1998 Apr; 246(1):37-40. PubMed ID: 9622202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.
    McWilliam N; Robbie L; Booth N; Bennett B
    Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.